论文标题
关于印度草药植物抑制COVID-19蛋白酶的抑制：一种硅研究
On the Inhibition of COVID-19 Protease by Indian Herbal Plants: An In Silico Investigation
论文作者
论文摘要
Covid-19迅速遍布全球，成为大流行。这种疾病在不同国家的文化规范，缓解工作和健康基础设施的影响都有可变的影响。在印度，大多数人依靠传统的印度医学来治疗人类疾病，因为成本较小，可用性较低，没有任何副作用。这些药是由草药植物制成的。这项研究旨在评估印度草药植物，以追求使用计算机方法中的潜在共证抑制剂。我们考虑了这些植物的11种不同种类的18种提取化合物。我们计算出的亲脂性，水溶性和提取化合物的结合亲和力表明抑制势在顺序上。 Harsingar>芦荟> Giloy>姜黄>蓝色> Ashwagandha>红洋葱> tulsi> tulsi>大麻>黑胡椒。在比较与羟氯喹的结合亲和力时，我们注意到Harsingar，Aloe Vera和Giloy提取物的抑制潜力非常有前途。因此，我们认为这些发现将开辟进一步的可能性，并加快为这种疾病寻找解毒剂的作品。
COVID-19 has quickly spread across the globe, becoming a pandemic. This disease has a variable impact in different countries depending on their cultural norms, mitigation efforts and health infrastructure. In India, a majority of people rely upon traditional Indian medicine to treat human maladies due to less-cost, easier availability and without any side-effect. These medicines are made by herbal plants. This study aims to assess the Indian herbal plants in the pursuit of potential COVID-19 inhibitors using in silico approaches. We have considered 18 extracted compounds of 11 different species of these plants. Our calculated lipophilicity, aqueous solubility and binding affinity of the extracted compounds suggest that the inhibition potentials in the order; harsingar > aloe vera > giloy > turmeric > neem > ashwagandha > red onion > tulsi > cannabis > black pepper. On comparing the binding affinity with hydroxychloroquine, we note that the inhibition potentials of the extracts of harsingar, aloe vera and giloy are very promising. Therefore, we believe that these findings will open further possibilities and accelerate the works towards finding an antidote for this malady.
